Magic mushroom therapy targets depression and addiction in heroes
NCT ID NCT07499583
First seen Apr 01, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This study tests whether a single dose of psilocybin (the active ingredient in magic mushrooms) combined with talk therapy is safe and can reduce depression and substance use in veterans and first responders who haven't responded to standard treatments. Fifty participants will receive one of three doses (5mg, 10mg, or 25mg) along with seven therapy sessions over 14 weeks. The goal is to ease symptoms and understand how the brain changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Goodman Hall, Dept of Psychiatry, Indiana University
Indianapolis, Indiana, 46202-3082, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
The Stark Neuroscience Building (Goodman Hall)
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.